• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例罕见亚型多发性骨髓瘤:继发性浆细胞白血病

A Case of Rare Subtype of Multiple Myeloma: Secondary Plasma Cell Leukemia.

作者信息

Sanwal Chandra, Mahmood Aftab, Bailey Michael, Patel Krutika, Guzman Antonio

机构信息

Graduate Medical Education, Corpus Christi Medical Center, Corpus Christie, TX.

Department of Pathology, Corpus Christi Medical Center, Corpus Christie, TX.

出版信息

HCA Healthc J Med. 2021 Feb 26;2(1):39-45. doi: 10.36518/2689-0216.1114. eCollection 2021.

DOI:10.36518/2689-0216.1114
PMID:37424883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10324726/
Abstract

Description Plasma cell leukemia is a rare, aggressive form of multiple myeloma with the presence of circulating plasma cells in the peripheral blood. There are two types of plasma cell leukemia, primary and secondary, depending on if there was previous evidence of multiple myeloma. The diagnostic criterion of plasma cell leukemia is based on a percentage (>20%) or an absolute number of (≥2 × 10/L) plasma cells in the peripheral circulation. We present the clinical course of a rare case of secondary plasma cell leukemia in a patient from the time of initial diagnosis of multiple myeloma, its remission period of about 5 years, and its final progression into refractory secondary plasma cell leukemia. This case report details the patient's presenting symptoms, pertinent laboratory and diagnostic imaging findings, and histopathology of peripheral blood and bone marrow. This case report presents a chronological comparison of key laboratory findings that manifest the progression of multiple myeloma into secondary plasma cell leukemia. It also offers a brief review of the literature for the diagnosis and treatment of plasma cell leukemia.

摘要

描述 浆细胞白血病是一种罕见的侵袭性多发性骨髓瘤形式,外周血中存在循环浆细胞。浆细胞白血病有原发性和继发性两种类型,这取决于之前是否有多发性骨髓瘤的证据。浆细胞白血病的诊断标准基于外周循环中浆细胞的百分比(>20%)或绝对数量(≥2×10⁹/L)。我们介绍了一名患者继发性浆细胞白血病的罕见病例的临床病程,从最初诊断多发性骨髓瘤开始,其缓解期约为5年,最终进展为难治性继发性浆细胞白血病。本病例报告详细描述了患者的症状、相关实验室检查和诊断影像学结果,以及外周血和骨髓的组织病理学。本病例报告按时间顺序比较了关键实验室检查结果,这些结果表明了多发性骨髓瘤向继发性浆细胞白血病的进展。它还简要回顾了浆细胞白血病诊断和治疗的文献。

相似文献

1
A Case of Rare Subtype of Multiple Myeloma: Secondary Plasma Cell Leukemia.一例罕见亚型多发性骨髓瘤:继发性浆细胞白血病
HCA Healthc J Med. 2021 Feb 26;2(1):39-45. doi: 10.36518/2689-0216.1114. eCollection 2021.
2
Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.原发性浆细胞白血病:两例浆细胞骨髓瘤罕见侵袭性变体病例报告并文献复习
Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):541-544. doi: 10.4103/0377-4929.191818.
3
Multiple myeloma and secondary plasma cell leukemia.多发性骨髓瘤和继发性浆细胞白血病。
Rom J Morphol Embryol. 2016;57(2 Suppl):837-839.
4
Plasma cell leukemia: from biology to treatment.浆细胞白血病:从生物学特性到治疗方法
Eur J Haematol. 2015 Jul;95(1):16-26. doi: 10.1111/ejh.12533. Epub 2015 Mar 16.
5
Plasma cell leukemia.浆细胞白血病。
Blood Rev. 2011 May;25(3):107-12. doi: 10.1016/j.blre.2011.01.005. Epub 2011 Feb 3.
6
Plasma cell leukemia: case series from a tertiary center with review of literature.浆细胞白血病:来自三级医疗中心的病例系列并文献复习
Indian J Hematol Blood Transfus. 2012 Mar;28(1):10-4. doi: 10.1007/s12288-011-0097-8. Epub 2011 Jul 21.
7
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.无富集的骨髓瘤患者样本单细胞检测与类器官基因分析以描绘循环稀有浆细胞克隆。
Curr Oncol. 2022 Apr 21;29(5):2954-2972. doi: 10.3390/curroncol29050242.
8
Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.印度人群浆细胞白血病的临床病理和实验室参数
Am J Blood Res. 2022 Dec 15;12(6):190-195. eCollection 2022.
9
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.浆细胞白血病:国际骨髓瘤工作组关于诊断要求、反应标准和治疗建议的共识声明。
Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21.
10
Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.浆细胞骨髓瘤和慢性淋巴细胞白血病/单克隆 B 细胞淋巴增生伴发骨髓累及的诊断和临床注意事项:15 例系列病例和文献复习。
Arch Pathol Lab Med. 2013 Apr;137(4):503-17. doi: 10.5858/arpa.2011-0696-OA.

本文引用的文献

1
Plasma Cell Leukemia: Definition, Presentation, and Treatment.浆细胞白血病:定义、表现和治疗。
Curr Oncol Rep. 2019 Jan 28;21(1):8. doi: 10.1007/s11912-019-0754-x.
2
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.继发性浆细胞白血病:101 例患者的多中心回顾性研究。
Leuk Lymphoma. 2019 Jan;60(1):118-123. doi: 10.1080/10428194.2018.1473574. Epub 2018 Jul 2.
3
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.埃罗妥珠单抗联合来那度胺/地塞米松治疗复发或难治性多发性骨髓瘤:ELOQUENT-2关于无进展生存期和肿瘤生长的随访及事后分析
Br J Haematol. 2017 Sep;178(6):896-905. doi: 10.1111/bjh.14787. Epub 2017 Jul 5.
4
Multiple myeloma and secondary plasma cell leukemia.多发性骨髓瘤和继发性浆细胞白血病。
Rom J Morphol Embryol. 2016;57(2 Suppl):837-839.
5
Plasma cell leukemia: from biology to treatment.浆细胞白血病:从生物学特性到治疗方法
Eur J Haematol. 2015 Jul;95(1):16-26. doi: 10.1111/ejh.12533. Epub 2015 Mar 16.
6
Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia.来那度胺(瑞复美)、硼替佐米(万珂)及地塞米松用于治疗继发性浆细胞白血病。
Leuk Lymphoma. 2015 Jan;56(1):232-5. doi: 10.3109/10428194.2014.893304. Epub 2014 Jun 27.
7
Prognostic value of 1p deletion for multiple myeloma: a meta-analysis.1p缺失对多发性骨髓瘤的预后价值:一项荟萃分析。
Int J Lab Hematol. 2014 Oct;36(5):555-65. doi: 10.1111/ijlh.12189. Epub 2014 Jan 27.
8
Secondary plasma cell leukemia.继发性浆细胞白血病
Rom J Morphol Embryol. 2012;53(4):1073-6.
9
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.浆细胞白血病:国际骨髓瘤工作组关于诊断要求、反应标准和治疗建议的共识声明。
Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21.
10
How I treat plasma cell leukemia.我如何治疗浆细胞白血病。
Blood. 2012 Sep 20;120(12):2376-89. doi: 10.1182/blood-2012-05-408682. Epub 2012 Jul 26.